Lozza G - Search Results

1

Cardioprotective effects of adenosine A1 and A2A receptor agonists in the isolated rat heart.

Lozza G, Conti A, Ongini E, Monopoli A. Lozza G, et al. Pharmacol Res. 1997 Jan;35(1):57-64. doi: 10.1006/phrs.1996.0120. Pharmacol Res. 1997. PMID: 9149317

2

Hemodynamic changes do not mediate the cardioprotection induced by the A1, adenosine receptor agonist CCPA in the rabbit.

Casati C, Forlani A, Lozza G, Monopoli A. Casati C, et al. Among authors: lozza g. Pharmacol Res. 1997 Jan;35(1):51-5. doi: 10.1006/phrs.1996.0114. Pharmacol Res. 1997. PMID: 9149316

3

Prolonged exposure to 5'-N-ethylcarboxamidoadenosine (NECA) does not affect the adenosine A2A-mediated vasodilation in porcine coronary arteries.

Conti A, Lozza G, Monopoli A. Conti A, et al. Among authors: lozza g. Pharmacol Res. 1997 Feb;35(2):123-8. doi: 10.1006/phrs.1996.0125. Pharmacol Res. 1997. PMID: 9175581

4

Cardiovascular pharmacology of the A2A adenosine receptor antagonist, SCH 58261, in the rat.

Monopoli A, Casati C, Lozza G, Forlani A, Ongini E. Monopoli A, et al. Among authors: lozza g. J Pharmacol Exp Ther. 1998 Apr;285(1):9-15. J Pharmacol Exp Ther. 1998. PMID: 9535988

5

Blockade of adenosine A2A receptors by SCH 58261 results in neuroprotective effects in cerebral ischaemia in rats.

Monopoli A, Lozza G, Forlani A, Mattavelli A, Ongini E. Monopoli A, et al. Among authors: lozza g. Neuroreport. 1998 Dec 1;9(17):3955-9. doi: 10.1097/00001756-199812010-00034. Neuroreport. 1998. PMID: 9875735

6

The A2A adenosine receptor mediates coronary vasodilation.

Belardinelli L, Shryock JC, Snowdy S, Zhang Y, Monopoli A, Lozza G, Ongini E, Olsson RA, Dennis DM. Belardinelli L, et al. Among authors: lozza g. J Pharmacol Exp Ther. 1998 Mar;284(3):1066-73. J Pharmacol Exp Ther. 1998. PMID: 9495868

7

Rapamycin, but not FK506 and GPI-1046, increases neurite outgrowth in PC12 cells by inhibiting cell cycle progression.

Parker EM, Monopoli A, Ongini E, Lozza G, Babij CM. Parker EM, et al. Among authors: lozza g. Neuropharmacology. 2000 Jul 24;39(10):1913-9. doi: 10.1016/s0028-3908(00)00028-9. Neuropharmacology. 2000. PMID: 10884572

8

Interleukin-10 modulates neuronal threshold of vulnerability to ischaemic damage.

Grilli M, Barbieri I, Basudev H, Brusa R, Casati C, Lozza G, Ongini E. Grilli M, et al. Among authors: lozza g. Eur J Neurosci. 2000 Jul;12(7):2265-72. doi: 10.1046/j.1460-9568.2000.00090.x. Eur J Neurosci. 2000. PMID: 10947805

9

Presenilin-1 regulates the neuronal threshold to excitotoxicity both physiologically and pathologically.

Grilli M, Diodato E, Lozza G, Brusa R, Casarini M, Uberti D, Rozmahel R, Westaway D, St George-Hyslop P, Memo M, Ongini E. Grilli M, et al. Among authors: lozza g. Proc Natl Acad Sci U S A. 2000 Nov 7;97(23):12822-7. doi: 10.1073/pnas.97.23.12822. Proc Natl Acad Sci U S A. 2000. PMID: 11070093 Free PMC article.

10

Nonsteroidal anti-inflammatory drugs increase tumor necrosis factor production in the periphery but not in the central nervous system in mice and rats.

Sacco S, Agnello D, Sottocorno M, Lozza G, Monopoli A, Villa P, Ghezzi P. Sacco S, et al. Among authors: lozza g. J Neurochem. 1998 Nov;71(5):2063-70. doi: 10.1046/j.1471-4159.1998.71052063.x. J Neurochem. 1998. PMID: 9798931 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

22 results

Search Page

Filters